Sarah Sammons/medicine.duke.edu
Jun 1, 2025, 16:25
Sarah Sammons: 50% of patients do not make it to second line therapy in mTNBC
Sarah Sammons, Breast Medical Oncologist and Senior Physician at Dana-Farber’s Breast Oncology Center, shared on X:
“Dr. Sonya Reid makes excellent point in Metastatic TNBC
Sadly 50% of patients do not make it to second line therapy in mTNBC. In that case, waiting beyond first line to give a more effective regimen seems silly.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 15, 2025, 16:51
Jul 15, 2025, 16:35
Jul 15, 2025, 16:28
Jul 15, 2025, 16:17
Jul 15, 2025, 16:13
Jul 15, 2025, 16:10
Jul 15, 2025, 16:01
Jul 15, 2025, 15:56